News Sentiment

0120G0 sentiment intelligence

Samyang Biopharm news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 53 Balanced news tone 5 relevant articles
Exchange KSC South Korea
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 44500.00 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 5

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-7.1% over one week, -12.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

New Samyang Holdings, Samsung Biologics spin-offs debut on Kospi

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -7.1% Price reacting lower
Trend fit Trend inactive -12.4% over four weeks
Fair value -40.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 5
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
The Korea Herald 2
BioWorld News 1
Chosunbiz 1
koreabiomed.com 1

Event Lens

What the news is about

Classified themes
Market update 5

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-5 of 5